Inge van Oort medical specialist

Inge van Oort completed her urological training in 2006. In that same year she started her fellowship in oncological urology. In 2009, she obtained her PhD on the clinical relevance of pathological findings after radical prostatectomy. Her main interest in oncological urology is the (surgical) treatment of prostate and bladder cancer. In research she has interests in finding new moleculair markers in prostate cancer and in the treatment of castration resistant prostate cancer. She also has been part of several large trials in CRPC (i.e Cougar 301 and 302(abiraterone) , Proselica and compassionate use program (cabazitaxel), Affirm and Previal (enzalutamide), provenge (sipuleucel-T), orteronel ). On national level was the chair of the working group on Oncological Urology (WOU) for 7 years, member of the board of education for residents (CCO). She is member of the multidisciplinairy Dutch guideline group on prostate cancer2018. At the EAU she’s a member of the EAU Guideline Office- new media group. In 2013 she received a grant from the Dutch cancer foundation for a study on Quality of care in prostate cancer treatment and in 2015 a grant from the ZonMW for a study on tumor response markers in combination with drug exposure measurement.Inge M. van Oort is member of national and international urological and oncological associations. She is also reviewer for national and international journals and member of the editorial board of the world journal of Urology.
People Inge van Oort

Contact

Inge van Oort MD PhD

contact

Inge van Oort medical specialist

Inge van Oort's main interest in oncological urology is the (surgical) treatment of prostate and bladder cancer. In research she has interests in finding new moleculair markers in prostate cancer and in the treatment of castration resistant prostate cancer.

read more

Additional functions

  • Member of NVU, EAU, AUA
  • coordinator of the prostate cancer outpatient clinic (2012 until now)
read more

Additional functions

  • Member of NVU, EAU, AUA
  • coordinator of the prostate cancer outpatient clinic (2012 until now)
  • Board member of the Dutch Uro-Oncology Studygroup (DUOS) (2016 until now)
  • social media Group EAU Guideline Office (2015- until now)
  • member of the Dutch prostatecancer Guidelines group (2012 until now)
  • board member/trainer for training Dutch urology residents
  • Oncology working group of the DUA (Dutch Urological Association), chair 2010-2017
  • (sub)-PI for several international studies on prostate cancer

Field of study

Urology

Social media

Radboud Institute for Molecular Life Sciences

Our main aim is to achieve a greater understanding of the molecular mechanisms of disease. By integrating fundamental and clinical research, we obtain multifaceted knowledge of (patho)physiological processes. read more